Quick Answer
BIOREGENX, INC. reported Total Assets of $508.5 thousand for the year ending 2024.
- BIOREGENX, INC. showed a decrease of -41.3% in Total Assets from 2023 to 2024.
- This data is from BIOREGENX, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $78.0 thousand | Q2 2023: $85.5 thousand | Q3 2023: $34.0 thousand | Q2 2024: $17.89 million | Q3 2024: $17.36 million | Q4 2024: $508.5 thousand | Q1 2025: $482.6 thousand | Q2 2025: $1.15 million | Q3 2025: $1.17 million.
- Over the full 4 years of available data (2021 to 2024), BIOREGENX, INC.'s Total Assets has grown by 298.0%.
- Historical annual values: Fiscal year 2024: $508.5 thousand | Fiscal year 2023: $865.8 thousand | Fiscal year 2022: $59.1 thousand | Fiscal year 2021: $127.8 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: